BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 11756856)

  • 41. Primary cauda equina lymphoma treated with high-dose methotrexate.
    Iwasaki M; Hida K; Yano S; Aoyama T; Kaneko S; Iwasaki Y
    Neurol Med Chir (Tokyo); 2012; 52(9):679-83. PubMed ID: 23006886
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Anterior lumbosacral radiculopathy after intrathecal methotrexate treatment.
    Koh S; Nelson MD; Kovanlikaya A; Chen LS
    Pediatr Neurol; 1999 Aug; 21(2):576-8. PubMed ID: 10465148
    [TBL] [Abstract][Full Text] [Related]  

  • 43. White-matter abnormalities in unirradiated patients cured of primary central nervous system lymphoma.
    Kim L; Hochberg FH; Shaeffer P
    Neuroradiology; 2000 Jun; 42(6):406-12. PubMed ID: 10929299
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Subacute leukencephalopathy after low-dose intrathecal methotrexate in an adolescent heterozygous for the MTHFR C677T polymorphism.
    Strunk T; Gottschalk S; Goepel W; Bucsky P; Schultz C
    Med Pediatr Oncol; 2003 Jan; 40(1):48-50. PubMed ID: 12426687
    [No Abstract]   [Full Text] [Related]  

  • 45. Paraneoplastic seesaw nystagmus and opsoclonus provides evidence for hyperexcitable reciprocally innervating mesencephalic network.
    Rizvi MT; Cameron L; Kilbane C; Shaikh AG
    J Neurol Sci; 2018 Jul; 390():239-245. PubMed ID: 29801897
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Methotrexate-induced myelopathy mimicking subacute combined degeneration of the spinal cord.
    Gosavi T; Diong CP; Lim SH
    J Clin Neurosci; 2013 Jul; 20(7):1025-6. PubMed ID: 23647709
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Methotrexate-related nonnecrotizing multifocal axonopathy detected by beta-amyloid precursor protein immunohistochemistry.
    Moore BE; Somers NP; Smith TW
    Arch Pathol Lab Med; 2002 Jan; 126(1):79-81. PubMed ID: 11800653
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Visual loss following treatment of sphenoid sinus carcinoma.
    Ebner R; Slamovits TL; Friedland S; Pearlman JL; Fowble B
    Surv Ophthalmol; 1995; 40(1):62-8. PubMed ID: 8545804
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The role of whole brain radiation in primary CNS lymphoma.
    Kasenda B; Loeffler J; Illerhaus G; Ferreri AJ; Rubenstein J; Batchelor TT
    Blood; 2016 Jul; 128(1):32-6. PubMed ID: 27207798
    [No Abstract]   [Full Text] [Related]  

  • 50. Long-term survival following radiotherapy and cytarabine chemotherapy for sporadic primary central nervous system lymphoma.
    Pöttgen C; Stuschke M; Stüben G; Schmitz A; Schwechheimer K; Wacker HH; Rauhut F; Kleuker S; Wilhelm H; Grehl S; Fehlings T
    Strahlenther Onkol; 2003 Sep; 179(9):626-32. PubMed ID: 14628129
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Intelligence quotient in childhood acute lymphoblastic leukemia after prophylactic treatment in central nervous system with 18 Gy cranial irradiation and intrathecal methotrexate.
    Liu HC; Liang DC; Chen SH; Lo CY; Tseng KP; Kuo TB; Chen HJ; Wang SJ
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1996; 37(2):107-10. PubMed ID: 8935408
    [TBL] [Abstract][Full Text] [Related]  

  • 52. NOA-03 trial of high-dose methotrexate in primary central nervous system lymphoma: final report.
    Herrlinger U; Küker W; Uhl M; Blaicher HP; Karnath HO; Kanz L; Bamberg M; Weller M;
    Ann Neurol; 2005 Jun; 57(6):843-7. PubMed ID: 15929034
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Re: Treatment of accidental intrathecal methotrexate overdose.
    Gosselin S; Isbister GK
    J Natl Cancer Inst; 2005 Apr; 97(8):609-10; author reply 610-1. PubMed ID: 15840887
    [No Abstract]   [Full Text] [Related]  

  • 54. [A case of intraocular lymphoma having retinal adverse events associated with intravitreal methotrexate].
    Kuroiwa N; Abematsu N; Matsuo Y; Nakao K; Sakamoto T
    Nippon Ganka Gakkai Zasshi; 2011 Jul; 115(7):611-6. PubMed ID: 21815491
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Sustained visual recovery after treatment with intrathecal methotrexate in a case of optic neuropathy caused by chronic lymphocytic leukemia.
    Mowatt L; Matthews T; Anderson I
    J Neuroophthalmol; 2005 Jun; 25(2):113-5. PubMed ID: 15937434
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Picture in clinical hematology no. 69--Case of asymptomatic limbic leukoencephalopathy due to methotrexate therapy].
    Kida J; Uemura M; Araya T; Matsumoto K; Imataki O; Takahashi T; Kimura N
    Rinsho Ketsueki; 2014 Jan; 55(1):1. PubMed ID: 24492028
    [No Abstract]   [Full Text] [Related]  

  • 57. [A case of lymphomatosis cerebri rapidly confirmed by brain biopsy].
    Yamaguchi N; Matsuda S; Yoshizawa T; Shigeeda R; Inoue T; Uchibori Y
    Rinsho Shinkeigaku; 2019 May; 59(5):286-289. PubMed ID: 31061303
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Transient encephalopathy following high-dose methotrexate.
    Lee AC; Li CH; Wong YC
    Med Pediatr Oncol; 2003 Jul; 41(1):101. PubMed ID: 12764767
    [No Abstract]   [Full Text] [Related]  

  • 59. Seesaw nystagmus caused by giant pituitary adenoma: case report.
    Moura FC; Gonçalves AC; Monteiro ML
    Arq Neuropsiquiatr; 2006 Mar; 64(1):139-41. PubMed ID: 16622572
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dorsal column myelopathy after intrathecal chemotherapy for leukemia.
    Pinnix CC; Chi L; Jabbour EJ; Milgrom SA; Smith GL; Daver N; Garg N; Cykowski MD; Fuller G; Cachia D; Kamiya-Matsuoka C; Woodman K; Dinardo C; Jain N; Kadia TM; Pemmaraju N; Ohanian M; Konopleva M; Kantarjian HM; Dabaja BS
    Am J Hematol; 2017 Feb; 92(2):155-160. PubMed ID: 27874212
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.